Carmen I. Rios

Carmen I. Rios

Auto-generated profile, based on publicly available information

Carmen I. Rios

RNCP, NIAID, NIH

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
OMOlivia Molinar-Inglis
Olivia Molinar-Inglis
ADAndrea L. DiCarlo
Andrea L. DiCarlo
PLPaula J. Lapinskas
Paula J. Lapinskas
CRCarmen I. Rios
Carmen I. Rios
MSMerriline Satyamitra
Merriline Satyamitra
DCDavid R. Cassatt
David R. Cassatt
Natural history studies have been informative in dissecting radiation injury, isolating its effects, and compartmentalizing injury based on the extent of exposure and the elapsed time post-irradiation. Although radiation injury models are useful for investigating the mechanism of action in isolated subsyndromes and development of medical countermeasures (MCMs), it is clear that ionizing radiation exposure leads to multi-organ injury (MOI). The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and Infectious Diseases partnered with the Biomedical Advanced Research and Development Authority to convene a virtual two-day meeting titled 'Radiation-Induced Multi-Organ Injury' on June 7-8, 2022. Invited subject matter experts presented their research findings in MOI, including study of mechanisms and possible MCMs to address complex radiation-induced injuries. This workshop report summarizes key information from each presentation and discussion by the speakers and audience participants. Understanding the mechanisms that lead to radiation-induced MOI is critical to advancing candidate MCMs that could mitigate the injury and reduce associated morbidity and mortality. The observation that some of these mechanisms associated with MOI include systemic injuries, such as inflammation and vascular damage, suggests that MCMs that address systemic pathways could be effective against multiple organ systems.

15 May 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
QLQian Liu
Qian Liu
TPThames Pickett
Thames Pickett
DHDeborah Hodge
Deborah Hodge
CRCarmen Rios
Carmen Rios
MAMichelle Arnold
Michelle Arnold
BRBarbara Rehermann
Barbara Rehermann

21 July 2025 in Disaster Medicine and Public Health Preparedness
Verified
Journal Article
Open access
PDF file
ADAndrea L. DiCarlo
Andrea L. DiCarlo
JBJonathan Button
Jonathan Button
DCDavid Cassatt
David Cassatt
ACArthur Chang
Arthur Chang
LFLauren Finklea
Lauren Finklea
MHMary Homer
Mary Homer
Since the early 2000s, the US Government has made purposeful investments to help ensure medical preparedness should a radiological or nuclear incident occur within its borders. This focused support of products to diagnose, mitigate, and treat radiation-induced bodily injuries that would be anticipated during a radiation public health emergency has involved many departments, ranging from multiple agencies within the Department of Health and Human Services to the Department of Defense. The intent of this manuscript is to convey information both on products that have been approved by the US Food and Drug Administration for radiation injuries during a radiation incident, as well as promising approaches under advanced stages of development. These products impact multiple organ systems (e.g., bone marrow, gastrointestinal tract, lungs, kidneys, skin) and have been tested for efficacy in a number of different small and large preclinical animal models. The successful development of these models, methods, products, and devices discussed herein demonstrate the importance of an intentionally collaborative, “one-government” approach to fostering radiation research, while also showcasing the need for critical public-private partnerships – all to ensure the safety of the public should the unthinkable occur.

19 October 2023 in Disaster Medicine and Public Health Preparedness
Verified
Journal Article
Open access
PDF file
MSMerriline Satyamitra
Merriline Satyamitra
DADevon K. Andres
Devon K. Andres
JBJulie N. Bergmann
Julie N. Bergmann
CHCorey M. Hoffman
Corey M. Hoffman
THThomas Hogdahl
Thomas Hogdahl
ADAndrea L. DiCarlo
Andrea L. DiCarlo
Purpose: To summarize presentations and discussions from the 2022 trans-agency workshop titled “Overlapping science in radiation and sulfur mustard (SM) exposures of skin and lung: Consideration of models, mechanisms, organ systems, and medical countermeasures.” Methods: Summary on topics includes: (1) an overview of the radiation and chemical countermeasure development programs and missions; (2) regulatory and industry perspectives for drugs and devices; 3) pathophysiology of skin and lung following radiation or SM exposure; 4) mechanisms of action/targets, biomarkers of injury; and 5) animal models that simulate anticipated clinical responses. Results: There are striking similarities between injuries caused by radiation and SM exposures. Primary outcomes from both types of exposure include acute injuries, while late complications comprise chronic inflammation, oxidative stress, and vascular dysfunction, which can culminate in fibrosis in both skin and lung organ systems. This workshop brought together academic and industrial researchers, medical practitioners, US Government program officials, and regulators to discuss lung-, and skin- specific animal models and biomarkers, novel pathways of injury and recovery, and paths to licensure for products to address radiation or SM injuries. Conclusions: Regular communications between the radiological and chemical injury research communities can enhance the state-of-the-science, provide a unique perspective on novel therapeutic strategies, and improve overall US Government emergency preparedness.

15 February 2023 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
ADAndrea L. DiCarlo
Andrea L. DiCarlo
DCDavid R. Cassatt
David R. Cassatt
CRCarmen I. Rios
Carmen I. Rios
MSMerriline Satyamitra
Merriline Satyamitra
YZYuji Zhang
Yuji Zhang
LTLanyn Taliaferro
Lanyn Taliaferro
Purpose: The intent of this mini review is to pay homage to Dr. John E. Moulder’s long and successful career in radiation science with the Medical College of Wisconsin. This effort will be done from the perspective of his history of U.S. Government funding for research into the biological pathways involved in radiation-induced normal tissue injuries, especially to damage to the kidneys and heart, and pharmacological interventions. In addition, the impact of his steady guidance and leadership in the mentoring of junior scientists, and the development of meaningful collaborations with other researchers will be highlighted. Conclusion: Dr. John E. Moulder’s contributions to the field of radiation research, through his strong character and reputation, his consistent and dedicated commitment to his colleagues and students, and his significant scientific advances, have been critical to moving the science forward, and will not be forgotten by those who knew him personally or through publications documenting his important work.

9 September 2026 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
JNJustin M. Napolitano
Justin M. Napolitano
MRMichael W. Rudokas
Michael W. Rudokas
LTLanyn Taliaferro
Lanyn Taliaferro
DCDavid R. Cassatt
David R. Cassatt
TWThomas A. Winters
Thomas A. Winters
ADAndrea L. DiCarlo
Andrea L. DiCarlo
In nearly all areas of scientific research, there are acknowledged differences in both access and responses to medical interventions across different populations. Further, there are existing biolog...